Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agile Therapeutics Inc (OP: AGRX )

1.510 UNCHANGED
Last Price Updated: 3:20 PM EDT, Aug 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.510
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 1.510
Today's Range 1.510 - 1.510
52wk Range 0.2000 - 1.520
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.
From Agile Therapeutics, Inc.
Via GlobeNewswire
AGRX Stock Earnings: Agile Therapeutics Reported Results for Q2 2024
Agile Therapeutics just reported results for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
+352.10%
+352.10%
1 Month
N/A
N/A
3 Month
+3.42%
+3.42%
6 Month
+264.12%
+264.12%
1 Year
+352.10%
+352.10%

More News

Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENV, SPR, UMBF, AGRX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INFN, SPR, AGRX, GRDI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SHCR, AGRX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
AGILE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Agile Therapeutics, Inc. - AGRX
From Kahn Swick & Foti, LLC
Via Business Wire
AGRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Agile Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
From Agile Therapeutics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.